Kansas-based ViroVax LLC has licensed their adjuvant for the use of Covaxin, which is currently undergoing advanced stages of clinical trials in India.(Representational Photo/REUTERS)

Bharat Biotech’s Covid-19 vaccine to use ViroVax’s adjuvant for longer-lasting immunity

By Rhythma Kaul | Hindustan Times, New Delhi
UPDATED ON OCT 05, 2020 12:08 PM IST
Bharat Biotech is currently conducting Phase 2 human trials of its Covid-19 vaccine candidate after receiving approval from the Drugs Controller General of India
Story Saved